You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 1, January 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (40)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Patterns of Brain Atrophy That Differentiate Corticobasal Degeneration Syndrome From Progressive Supranuclear Palsy

Adam L. Boxer, MD, PhD; Michael D. Geschwind, MD, PhD; Nataliya Belfor, PhD; Maria Luisa Gorno-Tempini, MD, PhD; Guido F. Schauer, BSc; Bruce L. Miller, MD; Michael W. Weiner, MD; Howard J. Rosen, MD

Arch Neurol. 2006;63:81-86.

Background  Progressive brain atrophy is associated with the corticobasal degeneration syndrome (CBDS) and progressive supranuclear palsy (PSP). Regional differences in brain atrophy may reflect the clinical features of disease.

Objective  To quantify the structural neuroanatomical differences between CBDS and PSP.

Design  A survey of neurologic deficits was conducted in all patients. Voxel-based morphometry was used to quantify structural neuroanatomical differences on magnetic resonance images in each subject group.

Setting  University hospital dementia clinic.

Participants  Fourteen patients who met clinical research criteria for CBD and 15 patients who met clinical research criteria for PSP, who were matched for severity of disease, age, and functional status, and 80 age-matched control subjects.

Main Outcome Measures  Statistically significant differences in regional gray and white matter volume, after multiple comparisons correction, between groups of subjects.

Results  The patients with CBDS displayed an asymmetric (left > right) pattern of brain atrophy that involved the bilateral premotor cortex, superior parietal lobules, and striatum. Progressive supranuclear palsy was associated with atrophy of the midbrain, pons, thalamus, and striatum, with minimal involvement of the frontal cortex. Midbrain structures were more atrophied in PSP than in CBD, whereas dorsal frontal and parietal cortices were more atrophied in CBD than in PSP. The degree of atrophy of the midbrain and pontine tegmentum and the left frontal eye field differentiated the 2 patient groups with 93% accuracy.

Conclusions  Distinct patterns of brain atrophy exist in CBDS and PSP that can be used to differentiate the 2 diseases. Assessments of brain atrophy in these disorders should be focused on cortical and brainstem ocular motor control areas.


Author Affiliations: Memory and Aging Center, Department of Neurology, University of California, San Francisco (Drs Boxer, Geschwind, Belfor, Gorno-Tempini, Miller, and Rosen and Mr Schauer); and Magnetic Resonance Spectroscopy Unit, San Francisco Veterans Administration Hospital (Drs Boxer and Weiner).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study
Whitwell et al.
Brain 2009;132:2932-2946.
ABSTRACT | FULL TEXT  

Association of Ideomotor Apraxia With Frontal Gray Matter Volume Loss in Corticobasal Syndrome
Huey et al.
Arch Neurol 2009;66:1274-1280.
ABSTRACT | FULL TEXT  

Diffusion Tensor Imaging Shows Different Topographic Involvement of the Thalamus in Progressive Supranuclear Palsy and Corticobasal Degeneration
Erbetta et al.
Am. J. Neuroradiol. 2009;30:1482-1487.
ABSTRACT | FULL TEXT  

Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy
Borroni et al.
Neurology 2008;71:1796-1803.
ABSTRACT | FULL TEXT  

Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease
Rizzo et al.
Brain 2008;131:2690-2700.
ABSTRACT | FULL TEXT  

White Matter Changes in Corticobasal Degeneration Syndrome and Correlation With Limb Apraxia
Borroni et al.
Arch Neurol 2008;65:796-801.
ABSTRACT | FULL TEXT  

Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease
Garbutt et al.
Brain 2008;131:1268-1281.
ABSTRACT | FULL TEXT  

Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations
Chen-Plotkin et al.
Neurology 2008;70:521-527.
ABSTRACT | FULL TEXT  

Distinct MRI Atrophy Patterns in Autopsy-Proven Alzheimer's Disease and Frontotemporal Lobar Degeneration
Rabinovici et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2008;22:474-488.
ABSTRACT  

Deformation-Based Morphometry Reveals Brain Atrophy in Frontotemporal Dementia
Cardenas et al.
Arch Neurol 2007;64:873-877.
ABSTRACT | FULL TEXT  

Rates of cerebral atrophy differ in different degenerative pathologies
Whitwell et al.
Brain 2007;130:1148-1158.
ABSTRACT | FULL TEXT  

Loss of insight in frontotemporal dementia, corticobasal degeneration and progressive supranuclear palsy
O'Keeffe et al.
Brain 2007;130:753-764.
ABSTRACT | FULL TEXT  

Mixing pro- and antisaccades in patients with parkinsonian syndromes
Rivaud-Pechoux et al.
Brain 2007;130:256-264.
ABSTRACT | FULL TEXT  

Structural anatomy of empathy in neurodegenerative disease
Rankin et al.
Brain 2006;129:2945-2956.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.